Synergistic effects of nimesulide and 5-fluorouracil on tumor growth and apoptosis in the implanted hepatoma in mice

World Journal of Gastroenterology

Volumn 9, Issue 5, 2003, Pages 936-940

  Li, Xiao Hong ^a   Li, Xiao Kun ^a   Cai, Shao Hui ^a   Tang, Fu Xing ^a   Zhong, Xue Yun ^b   Ren, Xian Da ^a  

^a JINAN UNIVERSITY   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FLUOROURACIL; NIMESULIDE; PROSTAGLANDIN E2; PROTEIN C FOS; PROTEIN C JUN; PROTEIN P53;

AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GRAFT; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; DNA STRUCTURE; DRUG EFFECT; DRUG POTENTIATION; FLOW CYTOMETRY; GENE OVEREXPRESSION; LIVER CELL CARCINOMA; LOW DRUG DOSE; MONOTHERAPY; MOUSE; NONHUMAN; PROSTAGLANDIN BLOOD LEVEL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; TUMOR CELL; ULTRASTRUCTURE; WESTERN BLOTTING;

EID: 0038205741     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i5.936     Document Type: Article

References (33)

1. Yoneda K, Yamamoto T, Osaki T. p53- and p21-independent apoptosis of squamous cell carcinoma cells induced by 5-fluorouracil and radiation. Oral Oncol 1998; 34: 529-537
2. Warr JR, Bamford A, Quinn DM. The preferential induction of apoptosis in multidrug-resistant KB cells by 5-fluorouracil. Cancer Lett 2002; 175: 39-44
3. Mizutania Y, Nakanishia H, Yoshidab O, Fukushimac M, Bonavidad B, Mikia T. Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil. Eur J Cancer 2002; 38: 167-176
4. Fukushima M, Fujioka A, Uchida J, Nakagawa F, Takechi T. Thymidylate synthase (TS) and ribonucleotide reductase (RNR) may be involved in acquired resistance to 5-fluorouracil (5-FU) in human cancer xenografts in vivo. Eur J Cancer 2001; 37: 1681-1687
5. Jean LG, Diana N, Brian PM, Vivian K, Francois JG. Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cells. Biochem Pharmacol 1999; 58: 477-486
6. Smith ML, Hawcroft G, Hull MA. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: Evidence of different mechanisms of action. Eur J Cancer 2000; 36: 664-674
7. Wu YL, Sun B, Zhang XJ, Wang SN, He HY, Qiao MM, Zhong J, Xu JY. Growth inhibition and apoptosis induction of Sulindac on human gastric cancer cells. World J Gastroenterol 2001; 7: 796-800
8. Li HL, Chen DD, Li XH, Zhang HW, Lü JH, Ren XD, Wang CC. JTE-522-induced apoptosis in human gastric adenocarcinoma cell line AGS cells by caspase activation accompanying cytochrome C release, membrane translocation of Bax and loss of mitochondrial membrane potential. World J Gastroenterol 2002; 8: 217-223
9. Li HL, Zhang HW, Chen DD, Zhong L, Ren XD, Si-Tu R. JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells. Acta Pharmacol Sin 2002; 23: 631-637
10. Geng HZ, Benjamin CYW, Chi KC, Kam CL, Lam SK. Differential apoptosis by indomethacin in gastric epithelial cells through the constitutive expression of Wild-Type p53 and/or Up-regulation of c-myc. Biochem Pharmacol 1999; 58: 193-200
11. Yaniv E, Fiorenza P, Galit L, Na'am K, Amiram R. Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivo. Biochem Pharmacol 2001; 61: 565-571
12. Maria P, Montserrat B, Mireia B, Beatriz B, Gabriel P. Aspirin induces apoptosis through mitochondrial cytochrome c release. FEBS Lett 2000; 480: 193-196
13. Munkarah AR, Morris R, Baumann P. Effects of prostaglandin E2 on proliferation and apoptosis of epithelial ovarian cancer cells. J Soc Gynecol Investig 2002; 9: 168-173
14. Ayumi D, Wakashi K, Akiko M, Hideki K, Yasutaka S, Osamu K, Toshifumi T,Masahiro T, Dai N, Hidetoshi T, Yoichi K. Increased expression of cyclooxyfenase-2 protein during rat hepatocarcinogenesis caused by a choline-deficient, L-amino acid-defined diet and chemopreventive efficacy of a specific inhibitor, nimesulide. Carcinogenesis 2002; 23: 245-256
15. Wang W, Qin SK, Chen BA, Chen HY. Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma. World J Gastroenterol 2001; 7: 702-705
16. Djordjevic B, Lange CS, Schwartz MA, Rotman M. Clonogenic inactivation of colon cancer-derived cells treated with 5-Fluorouracil and indomethacin in Hybrid Spheroids. Acta Oncol 1998; 37: 735-739
17. Yicong H, Curt MH, Samuel W. Regrowth of 5-Fluorouracil-treated human colon cancer cells is prevented by the combination of interferon γ, indomethacin, and phenylbutyrate. Cancer Res 2000; 60: 3200-3206
18. Xu CT, Huang LT, Pan BK. Current gene therapy for stomach carcinoma. World J Gastroenterol 2001; 7: 752-759
19. Shen ZY, Shen J, Li QS, Chen CY, Chen JY, Zeng Y. Morphological and functional changes of mitochondria in apoptosis esophaged carcinoma cells induced by arsenic trioxide. World J Gastroenterol 2002; 8: 31-35
20. Huang S, Li JY, Wu J, Meng L, Shou CC. Mycoplasma infections and different human carcinomas. World J Gastroenterol 2001; 7: 266-269
21. Huang X, Martindale JL, Liu Y, Holbrook NJ. The cellular response to oxidative stress: Influences of mitogen-activated protein kinase signalling pathways in cell survival. Biochem J 1998; 333: 291-300
22. Behens A, Sibilia M, Wagner EF. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet 1999; 21: 326-329
23. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407: 770-776
24. Fuchs SY, Adler V, Pincus MR, Ronai Z. MEKK1/JNK signaling stabilizes and activates p53. Proc Natl Acad Sci USA 1988; 95: 10541-10546
25. Andrea R, Shabbir M, Peter MY, Gohc SSN. Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer. Cancer Lett 2001; 172: 177-185
26. Li HL, Ren XD, Zhang HW, Ye CL, Lü JH, Zheng PE. Synergism between heparin and adriamycin on cell proliferation and apoptosis in human nasopharyngeal carcinoma CNE2 cells. Acta Pharmacol Sin 2002; 23: 167-172
27. Zhao AG, Zhao HL, Jin XJ, Yang JK, Tang LD. Effects of Chinese Jianpi herbs on cell apoptosis and related gene expression in human gastric cancer grafted onto nude mice. World J Gastroenterol 2002; 8: 792-796
28. Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002; 8; 385-392
29. Zhang Z, Yuan Y, Gao H, Dong M, Wang L, Gong YH. Apoptosis, proliferation and p53 gene expression of H. pylori associated gastric epithelial lesions. World J Gastroenterol 2001; 7: 779-782
30. Xu AG, Li SG, Liu JH, Gan AH. Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer. World J Gastroenterol 2001; 7: 403-406
31. Toshiyuki A, Yasushi E, Naoko I, Shinichi A, John CR, Hiroshi H. Changes in c-Jun but not Bcl-2 family proteins in p53-dependent apoptosis of mouse cerebellar granule neurons induced by DNA damaging agent bleomycin. Brain Res 1998; 794: 239-247
32. James DH, Mahmood AS, Roberta M, Amancio C, Gregory JH, David HB. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 1999; 190: 1375-1382
33. Pritcharda MD, Jackmanb A, Christopher SP, John AH. Chemically-induced apoptosis: p21 and p53 as determinants of enterotoxin activity. Toxicol Lett 1998; 102-103: 19-27